Assessment of Changes over Time of Lipid Profile, C-Reactive Protein Level and Body Mass Index in Teenagers and Young Adults on Different Diets Belonging to Autism Spectrum Disorder.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
26 Aug 2020
Historique:
received: 10 07 2020
revised: 21 08 2020
accepted: 24 08 2020
entrez: 30 8 2020
pubmed: 30 8 2020
medline: 31 3 2021
Statut: epublish

Résumé

Numerous scientific studies on patients with autism spectrum disorder (ASD) suggest a significant role of inflammation processes or lipid disorders in this spectrum of neurodevelopmental disorders. Unfortunately, there is a lack of assessments of changes over time regarding level of lipids and inflammatory markers in people diagnosed with ASD using different diets. The aim of this study was to evaluate changes in lipid profile, high sensitivity C-reactive protein (hs-CRP) and body mass index (BMI) in individuals diagnosed with ASD and healthy controls. Variables were assessed at two time points (2015/17 and 2017/20) for each subject. After applying the selection criteria, for the first assessment period, 96 participants were qualified (the group consisted of 59 males with ASD and 37 healthy volunteers, i.e., age-matched control group-CG). The final assessment included 93 participants (57 from ASD group and 36 from CG). Subjects were on low-fat diet (LFD), gluten-casein-free diet (GF-CF) and regular diet (RD), respectively. All members of CG were on regular diet. A fasting lipid profile and hs-CRP level were analyzed. BMI and percentiles were calculated. Eating habits were checked by analyzing data from questionnaires. Principal component analysis (PCA) was used separately for every assessment. The Mann-Whitney U test was used to compare the medians of variables in the scheme of pairwise comparisons between control and ASD groups on different diets for separate assessment, while differences over time between variables were tested by Wilcoxon signed-rank test. Statistically significant differences between BMI, CRP, triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), non-HDL-C and TC/HDL ratio were found in ASD group in comparison to healthy volunteers (increased BMI, CRP and TC/HDL and decreased HDL-C for all types of diets, increased TG in the group of LFD and RD individual and increased non-HDL-C in the group of GF-CF and RD individuals) during the first assessment period. The second assessment over time also showed increased levels of TC, non HDL-C and TC/HDL and decreased level of HDL-C for all ASD individuals regardless of diets used, while BMI and CRP increased only for individuals on LFD and RD. No statistically significant correlations between age of participants and other variables comparing with CG were found. Our studies suggest that targeted, individualized nutritional pattern and periodic screening for lipid and immune disorders would be beneficial for teenagers and adults diagnosed with ASD.

Sections du résumé

BACKGROUND BACKGROUND
Numerous scientific studies on patients with autism spectrum disorder (ASD) suggest a significant role of inflammation processes or lipid disorders in this spectrum of neurodevelopmental disorders. Unfortunately, there is a lack of assessments of changes over time regarding level of lipids and inflammatory markers in people diagnosed with ASD using different diets. The aim of this study was to evaluate changes in lipid profile, high sensitivity C-reactive protein (hs-CRP) and body mass index (BMI) in individuals diagnosed with ASD and healthy controls. Variables were assessed at two time points (2015/17 and 2017/20) for each subject.
METHODS METHODS
After applying the selection criteria, for the first assessment period, 96 participants were qualified (the group consisted of 59 males with ASD and 37 healthy volunteers, i.e., age-matched control group-CG). The final assessment included 93 participants (57 from ASD group and 36 from CG). Subjects were on low-fat diet (LFD), gluten-casein-free diet (GF-CF) and regular diet (RD), respectively. All members of CG were on regular diet. A fasting lipid profile and hs-CRP level were analyzed. BMI and percentiles were calculated. Eating habits were checked by analyzing data from questionnaires. Principal component analysis (PCA) was used separately for every assessment. The Mann-Whitney U test was used to compare the medians of variables in the scheme of pairwise comparisons between control and ASD groups on different diets for separate assessment, while differences over time between variables were tested by Wilcoxon signed-rank test.
RESULTS RESULTS
Statistically significant differences between BMI, CRP, triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), non-HDL-C and TC/HDL ratio were found in ASD group in comparison to healthy volunteers (increased BMI, CRP and TC/HDL and decreased HDL-C for all types of diets, increased TG in the group of LFD and RD individual and increased non-HDL-C in the group of GF-CF and RD individuals) during the first assessment period. The second assessment over time also showed increased levels of TC, non HDL-C and TC/HDL and decreased level of HDL-C for all ASD individuals regardless of diets used, while BMI and CRP increased only for individuals on LFD and RD. No statistically significant correlations between age of participants and other variables comparing with CG were found.
CONCLUSIONS CONCLUSIONS
Our studies suggest that targeted, individualized nutritional pattern and periodic screening for lipid and immune disorders would be beneficial for teenagers and adults diagnosed with ASD.

Identifiants

pubmed: 32859040
pii: nu12092594
doi: 10.3390/nu12092594
pmc: PMC7551291
pii:
doi:

Substances chimiques

Biomarkers 0
Lipids 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

NPJ Sci Food. 2017 Oct 30;1:2
pubmed: 31304244
Transl Psychiatry. 2013 Jun 18;3:e273
pubmed: 23778583
J Neuroimmune Pharmacol. 2013 Sep;8(4):900-20
pubmed: 23645137
Open Biochem J. 2010 Jun 10;4:72-6
pubmed: 20676221
Nutr Metab (Lond). 2011 Jun 08;8(1):34
pubmed: 21651783
Neuroimmunomodulation. 2014;21(2-3):109-16
pubmed: 24557043
J Autism Dev Disord. 2013 Aug;43(8):1895-909
pubmed: 23224514
Psychiatry Res. 2007 Jan 15;149(1-3):321-4
pubmed: 17123635
Soc Psychiatry Psychiatr Epidemiol. 2011 Dec;46(12):1283-93
pubmed: 20938640
Nutrients. 2018 Mar 17;10(3):
pubmed: 29562612
Nutr Res. 2010 Apr;30(4):255-60
pubmed: 20534328
J Trace Elem Med Biol. 2016 Mar;34:32-7
pubmed: 26854242
Front Nutr. 2018 May 18;5:40
pubmed: 29868601
Acta Psychiatr Scand. 2017 May;135(5):373-387
pubmed: 28122130
Rocz Panstw Zakl Hig. 2013;64(1):1-12
pubmed: 23789306
Autism Res Treat. 2014;2014:164938
pubmed: 24734177
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
Mol Psychiatry. 2014 Feb;19(2):259-64
pubmed: 23337946
Int J Environ Res Public Health. 2019 Feb 23;16(4):
pubmed: 30813406
Mol Autism. 2014 Jan 27;5(1):4
pubmed: 24467795
Neuropsychopharmacology. 2004 Jul;29(7):1221-9
pubmed: 15085088
Brain Behav Immun. 2017 Aug;64:208-219
pubmed: 28089638
Mol Autism. 2011 Aug 02;2:13
pubmed: 21810230
J Altern Complement Med. 2008 Jan-Feb;14(1):79-85
pubmed: 18199019
Pharmaceuticals (Basel). 2018 Jun 04;11(2):
pubmed: 29867038
Curr Clin Pharmacol. 2014;9(4):335-49
pubmed: 24050740
Ital J Pediatr. 2017 Sep 21;43(1):86
pubmed: 28934988
Brain Behav Immun. 2012 Jan;26(1):170-6
pubmed: 21933705
J Neuroinflammation. 2011 May 19;8:52
pubmed: 21595886
J Child Psychol Psychiatry. 2017 Jun;58(6):744-747
pubmed: 28524462
Neurobiol Dis. 2019 Dec;132:104544
pubmed: 31351171
Nutrients. 2016 Apr 21;8(4):236
pubmed: 27110819
Int Rev Psychiatry. 2008 Apr;20(2):165-70
pubmed: 18386207
Nutr Neurosci. 2019 Mar;22(3):145-155
pubmed: 28762296
Depress Anxiety. 2013 Apr;30(4):297-306
pubmed: 23468190
Int J Mol Sci. 2017 Jul 03;18(7):
pubmed: 28671614
Healthcare (Basel). 2017 Feb 03;5(1):
pubmed: 28165367
Open Access Maced J Med Sci. 2015 Jun 15;3(2):262-7
pubmed: 27275232
Adv Nutr. 2015 Jul 15;6(4):397-407
pubmed: 26178024
J Trace Elem Med Biol. 2017 Sep;43:9-14
pubmed: 27707611
Pediatric Health Med Ther. 2015 Sep 28;6:153-166
pubmed: 29388597

Auteurs

Anna Błażewicz (A)

Chair of Chemistry, Department of Analytical Chemistry, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland.

Iwona Szymańska (I)

Faculty of Medicine, Student Research Team, Department of Analytical Chemistry, Medical University of Lublin, 20-093 Lublin, Poland.

Aleksander Astel (A)

Department of Biology and Earth Sciences, Pomeranian University in Słupsk, 22a Arciszewskiego Street, 76-200 Słupsk, Poland.

Agnieszka Stenzel-Bembenek (A)

Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.

Wojciech Remington Dolliver (WR)

The Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Agata Makarewicz (A)

I Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, 1 Gluska Street, 20-439 Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH